PubRank

Patrick Lebecque

Author PubWeight™ 30.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med 2007 4.03
2 Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. Am J Respir Crit Care Med 2007 2.18
3 A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential difference. J Cyst Fibros 2012 2.05
4 Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Hum Mutat 2009 1.71
5 Comparison of spirometric reference values. Pediatr Pulmonol 2004 1.28
6 Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice. Respir Res 2006 1.12
7 Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. Am J Respir Cell Mol Biol 2009 1.11
8 Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates? Pediatr Res 2004 1.02
9 Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney. J Am Soc Nephrol 2007 1.02
10 Basic protocol for transepithelial nasal potential difference measurements. J Cyst Fibros 2004 1.01
11 An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis. Clin Biochem 2007 0.93
12 Transient elastography in patients with cystic fibrosis. Pediatr Radiol 2010 0.92
13 Omalizumab for treatment of ABPA exacerbations in CF patients. Pediatr Pulmonol 2009 0.91
14 Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients. BMC Microbiol 2010 0.87
15 Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosis. PLoS One 2013 0.85
16 Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice. J Cyst Fibros 2009 0.84
17 Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice. Am J Respir Crit Care Med 2009 0.84
18 Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation. Diabetes Care 2007 0.84
19 Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in docosahexaenoic acid. J Nutr 2009 0.82
20 Molecular typing and antifungal susceptibility of Exophiala isolates from patients with cystic fibrosis. J Med Microbiol 2012 0.82
21 Airway ion transport impacts on disease presentation and severity in cystic fibrosis. Clin Biochem 2008 0.81
22 Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis. Clin Chem 2007 0.81
23 Modified method to measure nasal potential difference. Clin Chem Lab Med 2003 0.79
24 Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. J Cyst Fibros 2011 0.78
25 Miglustat effects on the basal nasal potential differences in cystic fibrosis. J Cyst Fibros 2012 0.75
26 The objective assessment of cough frequency: accuracy of the LR102 device. Cough 2011 0.75
27 Outer diameter of the vermiform appendix: not a valid sonographic criterion for acute appendicitis in patients with cystic fibrosis. AJR Am J Roentgenol 2005 0.75
28 Objective study of sensor relevance for automatic cough detection. IEEE J Biomed Health Inform 2013 0.75